FDA Inspection
Baxter Pharmaceuticals India Pvt LtdBaxter Pharmaceuticals India Pvt Ltd – FDA Inspection, Aug 4, 2017
Record Details
This FDA Inspection record concerns Baxter Pharmaceuticals India Pvt Ltd, with an inspection on August 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ce96d7e2-c444-469f-913c-22f716c9bd65
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1028732
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Baxter Pharmaceuticals India Pvt Ltd
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | Not classified | Office of Inspections and Investigations | |
| January 27, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2017 | Not classified | Office of Inspections and Investigations | |
| August 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Pharmaceuticals India Pvt Ltd
- FDA Inspection 1280282 - 2025-06-27
- FDA Inspection 1195842 - 2023-01-27
- FDA Inspection 1169631 - 2022-05-17
- FDA Inspection 1019107 - 2017-05-31
- FDA Inspection 986348 - 2016-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.